Newsroom
The latest featured press and company announcements from Genomenon.
For general press inquiries, please contact Colleen McMillen, VP of Marketing: cmcmillen@genomenon.com
2,000
Clinical Labs rely on Mastermind
50%
of the clinical exome has been curated by Genomenon
100+
Grad-level Scientists power Genomenon’s genomic intelligence development
145+
Countries around the world have labs powered by Mastermind
News
Read the latest coverage featuring Genomenon.
Dec 10, 2024
Perspective: The Future of Precision Medicine Depends on Collaboration Across the Healthcare Landscape
Nov 12, 2024
The Variant Interpretation Bottleneck in Genomics for Oncology Clinical Research is Opening, say Illumina, Genomenon
Nov 7, 2024
GenomOncology and Genomenon Partner to Enhance Germline Variant Classification and Genomic Reporting
Mar 29, 2024
An Established Relationship: How semi-automated biomedical evidence curation could open up genetic diagnostics
Jun 30, 2023
Genomenon Accelerates Quest Curate Entire Human Genome Boston Genetics Acquisition
Feb 7, 2023
Genomenon, Flagship Biosciences Partner Biomarker Discovery, Companion Dx Development
Oct 31, 2022
Novel Solution Increases Diagnostic Yield, Accelerates Rare Disease Diagnoses
Aug 25, 2022
BeginNGS Program Pediatric Rare Disease Dx, Treatment Rapid NGS, Data Curation
Aug 24, 2022
Novel newborn screening whole genome sequencing acute management guidance screen diagnosis genetic diseases
Announcements
Events
Meet the Genomenon team at one of the following industry events:
January 13, 2025
BIO Partnering @ JPM Week
San Francisco, CA
Make BIO your home base for meetings during JPM Week. The BIO One-on-One Partnering™ system lets you efficiently arrange meetings with biotechs, investors, in-licensors, medical device and medtech companies, and other life science leaders. Schedule a meeting with the Genomenon leadership team at JPM.
.png){kind=logo}
February 5, 2025
Precision Medicine World Conference (PMWC)
Silicon Valley, CA
Meet the team at PMWC 2025! Genomenon Founder and Chief Scientific Officer, Mark Kiel, MD, PhD, will be presenting on how our next-generation AI brings powerful new insight into genomic data, and how we're transforming patient care by uncovering the genomic drivers of genetic disease and cancer.